Option chain shows key data for Anthera Pharmaceuticals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Anthera Pharmaceuticals.

Anthera Pharmaceuticals (OTC:ANTH) Stock, Option Chain

Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company currently has one Phase 3-ready clinical program and two Phase 2 clinical programs. It was established in 2004.

Long Ideas

Health Care

Media

Trading Ideas

General

ANTH

ANTM

On CNBC&#39;s &#34;Trading Nation,&#34; Quint Tatro of Joule Financial and JC O&#39;Hara of MKM Partners spoke about the health care stocks.

&#39;Trading Nation&#39; Analysts Give Their Health Care Picks

News

Movers & Shakers

Intraday Update

Markets

Movers

ADGO

AEMD

AFOM

AFTM

AIGI

AMRH

ANIX

APCDF

APDN

AQMS

AVMR

BBLKF

BKPPF

BLOZF

BNFT

BRVVF

CDXI

CFPUF

CONN

CORV

CWGL

CXRXF

DESTQ

DMSI

DRRSF

DXBRF

EFIR

EFSH

ENZC

ETFLF

FAMI

FCUUF

FEIM

FNGR

GIGA

GRST

GTIM

GXXM

HIPH

HSEEF

HVBTF

INAP

ISWH

JFIN

KOSCF

KPAY

LOVE

LPCN

MARA

MDFZF

MJGCF

MOSC

MPCIY

MSPC

MYRLF

NUBEVA TECH LTD ORD by Nubeva Technologies Ltd.

NBVAF

NIMU

NTTHF

PHVAF

PNWRF

PPSI

PSIX

PWRMF

RMBL

RTMAF

RVRA

SEDO

SGBX

SINO

SNNA

SPVNF

STTH

TLGT

TRAGF

TRHC

TTTSF

UBQU

VCSY

VIBI

VRTHF

WTER

YUANF

MCARY

AMTCQ

Stocks That Hit 52-Week Lows On Friday

Biotech

Earnings

Offerings

IPOs

ACST

ALKS

AMGN

APTX

AQXP

BTAI

CSII

CYTX

EDGE

ERYP

EYEG

EYEN

FTSV

IDRA

KURA

ONCY

PTIE

RCUS

SMMT

SNDX

SNGX

STIM

TBIO

TCDA

ZFGN

Benzinga&#39;s Daily Biotech Pulse: Eli Lilly, Edge Therapeutics, BioXcel Report Positive Trial Results, 4 Stocks Debut

ANTHERA PHARMS INC NEW by Anthera Pharmaceuticals, Inc.

Anthera Pharmaceuticals Inc

On <a href="https://www.cnbc.com/video/2020/11/05/health-care-stocks-surge-with-election-outcome-still-uncertain.html">CNBC&#39;s &quot;Trading Nation,&quot;</a> Quint Tatro of Joule Financial and JC O&#39;Hara of MKM Partners spoke about the health care stocks. It seems that prospects of divided government are good for the sector as the health care stocks traded higher in the week after the election.
Tatro sees opportunities in the space, but he wouldn&#39;t chase the health care stocks. Two of his favorite names in the sector are Pfizer Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pfe#NYSE">PFE</a>) and Merck &amp; Co., Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mrk#NYSE">MRK</a>). They have a better balance sheet than most but&nbsp;are still highly levered. He thinks they&#39;re a good addition for a portfolio, but he wouldn&#39;t chase them.
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/20/11/18209005/health-insurance-stocks-soar-as-sector-avoids-worst-case-election-scenario">Health Insurance Stocks Soar As Sector Avoids Worst-Case Election Scenario</a>
Some of the most important breakouts in the sector came from the managed care stocks, like UnitedHealth Group Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/unh#NYSE">UNH</a>), Cigna Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ci#NYSE">CI</a>) and Anthem Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/antm#NYSE">ANTM</a>), said O&#39;Hara. He bought Anthem on Thurdsay.
He explained that the stock might be stretched in the short term, but it&#39;s breaking out above the resistance, which speaks for further upside. O&#39;Hara sees at least 20% of upside for Anthem and he has a technical target of $400 for the stock.

Comments

Anthera Pharmaceuticals

Anthera Pharmaceuticals (ANTH) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga